{"id":"fidaxomicin-oral-suspension","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fidaxomicin binds to bacterial RNA polymerase and inhibits transcription in C. difficile, leading to bacterial cell death. Its narrow spectrum of activity and minimal systemic absorption make it particularly effective for treating C. difficile infection (CDI) while preserving beneficial commensal bacteria in the gastrointestinal tract.","oneSentence":"Fidaxomicin is a macrocyclic antibiotic that inhibits bacterial RNA polymerase, selectively killing Clostridioides difficile while minimizing effects on normal gut flora.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:12:32.635Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection (CDI), including initial and recurrent episodes"}]},"trialDetails":[{"nctId":"NCT07120490","phase":"NA","title":"STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-10","conditions":"Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Fecal Microbiota Transplantation (FMT)","enrollment":424},{"nctId":"NCT02218372","phase":"PHASE3","title":"A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2015-01-09","conditions":"Clostridium Difficile-associated Diarrhea (CDAD)","enrollment":148},{"nctId":"NCT05077085","phase":"PHASE4","title":"Bezlotoxumab Versus FMT for Multiple Recurrent CDI","status":"WITHDRAWN","sponsor":"Leiden University Medical Center","startDate":"2022-01","conditions":"Clostridium Infections, Clostridioides Difficile, Enterocolitis, Pseudomembranous","enrollment":""},{"nctId":"NCT01591863","phase":"PHASE2","title":"Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)","status":"COMPLETED","sponsor":"Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2012-06-15","conditions":"Clostridium Difficile-associated Diarrhea","enrollment":38},{"nctId":"NCT01533844","phase":"","title":"To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis","status":"TERMINATED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2012-03","conditions":"Clostridium Difficile","enrollment":1}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dificid","Dificlir"],"phase":"phase_3","status":"active","brandName":"Fidaxomicin oral suspension","genericName":"Fidaxomicin oral suspension","companyName":"Astellas Pharma Europe B.V.","companyId":"astellas-pharma-europe-b-v","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fidaxomicin is a macrocyclic antibiotic that inhibits bacterial RNA polymerase, selectively killing Clostridioides difficile while minimizing effects on normal gut flora. Used for Clostridioides difficile infection (CDI), including initial and recurrent episodes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}